Penlac and Lyrica drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Penlac (ciclopirox) and Lyrica (pregabalin). Common drug interactions include arthralgia among females and brachial plexus injury among males.

The phase IV clinical study analyzes what interactions people have when they take Penlac and Lyrica. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Penlac?

Penlac has active ingredients of ciclopirox. eHealthMe is studying from 492 Penlac users. Check the latest studies of Penlac.

What is Lyrica?

Lyrica has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 261,646 Lyrica users. Check the latest studies of Lyrica.



On May, 29, 2026

76 people who take Penlac and Lyrica together, and have interactions are studied.

Penlac and Lyrica drug interactions.

What are the common drug interactions of Penlac and Lyrica, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Drug ineffective
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Vertigo
  5. Fall
  6. Peripheral swelling
  7. Upper limb fracture
  8. Neuropathy peripheral (surface nerve damage)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Gait disturbance

male:

  1. Brachial plexus injury (brachial plexus injuries, are caused by damage to those nerves network that conducts signals from the spinal cord)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Migraine (headache)
  5. Multiple injuries
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Respiratory tract infection
  8. Thyroid disorder (thyroid diseases)
  9. Urinary tract infection

What are the common drug interactions of Penlac and Lyrica, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Brachial plexus injury (brachial plexus injuries, are caused by damage to those nerves network that conducts signals from the spinal cord)
  2. Migraine (headache)
  3. Thyroid disorder (thyroid diseases)

30-39:

  1. Cardiac disorder
  2. Pancreatic disorder
  3. Renal disorder (kidney disease)

40-49:

  1. Dehydration (dryness resulting from the removal of water)
  2. Dizziness
  3. Erythrasma (skin disease that causes brown, scaly skin patches)
  4. Injection site extravasation (flow of (blood or lymph) from injection site)
  5. Injection site nerve damage
  6. Injection site pain
  7. Injection site rash
  8. Limb discomfort (discomfort in leg)
  9. Pain in extremity
  10. Infusion site haemorrhage (bleeding from infusion site)

50-59:

  1. Device related infection
  2. Diplopia (double vision)
  3. Dizziness
  4. Dry eye (lack of adequate tears)
  5. Dry mouth
  6. Dyspnoea (difficult or laboured respiration)
  7. Dysuria (painful or difficult urination)
  8. Eye irritation
  9. Facial pain
  10. Fatigue (feeling of tiredness)

60+:

  1. Arthralgia (joint pain)
  2. Pain in extremity
  3. Gait disturbance
  4. Nervousness
  5. Blindness
  6. Confusional state
  7. Eye pain
  8. Head injury
  9. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

What are the existing conditions these people have? *

  1. Pain: 32 people, 42.11%
  2. Stress And Anxiety: 21 people, 27.63%
  3. Nausea (feeling of having an urge to vomit): 17 people, 22.37%
  4. Joint Pain: 15 people, 19.74%
  5. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 13 people, 17.11%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 13 people, 17.11%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 12 people, 15.79%
  8. Abdominal Pain: 12 people, 15.79%
  9. Bipolar Disorder (mood disorder): 12 people, 15.79%
  10. Neuropathy Peripheral (surface nerve damage): 12 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take Penlac and Lyrica?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Penlac and Lyrica:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Penlac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lyrica:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Penlac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lyrica and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox and pregabalin (the active ingredients of Penlac and Lyrica, respectively), and Penlac and Lyrica (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: